PerkinElmer to Divest Proteomics Business to Concentrate on Human, Environmental Health
February 05, 2009
PerkinElmer to Divest Proteomics Business to Concentrate on Human, Environmental Health
By Tony Fong
It was not immediately clear whether PerkinElmer would divest all of its proteomics assets or retain a portion of them, though it described them as “discontinued operations” during its fourth-quarter earnings statement.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.